Treating Glaucoma with Medical Marijuana
Medical Marijuana Awareness Post-Webinar Resources
Thank you to everyone who attended the March 17th Medical Marijuana Awareness webinar on Glaucoma and Medical Marijuana!
Watch the video on our YouTube Channel! Your questions and comments during the live Q&A helped to make a great source of information for the next person seeking treatment.
Speakers featured in this webinar were host Marc Matoza, and Chris Cano, Executive Director for Suncoast NORML.
We’ve partnered with medical marijuana education experts to provide you further resources on the topic of Glaucoma and Medical Marijuana.
Click an item from the index below to skip to that section.
Overview: What is Glaucoma?
- Medical Marijuana 101 Patient Information Brochure
- MMTCFL Chronic Conditions Resources
- How Cannabis Works on the Human Body: The Endocannabinoid System, Cannigma
Materials from the Webinar
- View the slides from the live presentation
- How CBD Oil Affects Chronic Pain and Inflammation with Thomas DeLauer
- Weed (Parts 1-4) with Dr. Sanjay Gupta
Meet the Speakers
President, Marijuana Med Today
Marc is a technology and business development manager with expertise in technology, database, cybersecurity, and online/web/mobile computing. As an inventor, computer scientist, and entrepreneur, he has developed innovative tech products including a leading relational database, multiple digital multilingual dictionaries, a digital bilingual reference/grammar-checking word processing add-on, golf [sports] swing video capture & analysis solutions, and certified safe anti-microbial environments.
Marc’s multinational background includes technology and corporate management experience with Hewlett Packard, Netscape Communications, Ashton-Tate, AlphaGraphics SA, MarcTech SA/LLC, and Swing Solutions. This includes managing operations in Europe, Latin America, Canada, and the USA. He has a Computer Science Degree from California Polytechnic State University.
Guest Speaker on Glaucoma
Executive Director, Suncoast NORML
Christopher Cano is a United States Air Force Veteran and Public Administrator who currently serves as an organizer for social justice. Armed with multiple degrees from the University of South Florida and years of experience in Florida politics, Chris strives to be at the forefront of multiple movements working to affect change in America. Currently he serves on several local and state-wide boards of various nonprofit and advocacy organizations. His scholarly work, A Comparative and Policy Analysis of Cannabis Prohibition with Recommendations for Florida’s Medical Marijuana System, was lauded by fellow academics as the most in-depth research on the subject ever conducted by a student from the University of South Florida’s School of Public Affairs. Christopher’s professional experience working as a Legislative Analyst in the Florida Legislature, for several Social Justice Organizations, and a major Fortune 500 Company in the Pharmaceutical Industry give him a wealth of knowledge that he applies everyday. His post-graduate work as a Professor teaching educational seminars combined with his professional and his academic experience make him one of the top industry professionals. Chris currently serves as Executive Director for the Suncoast Chapter of the National Organization for the Reform of Marijuana Laws in the state of Florida.
What is Glaucoma?
Overview by Medical Marijuana Treatment Clinics of Florida
Glaucoma is a condition that causes damage to the optic nerve, which is responsible for carrying visual information from the eye to the brain. Glaucoma could have a hereditary factor and typically does not appear in patients until they are older than 60, but it is not unheard of for younger people to develop or even be born with the condition.
See Also from MMTCFL:
The Florida Atlantic University College of Nursing is conducting a study to better understand the health impact of medical marijuana in older adults. If you are 60 or older, please consider taking this survey and assisting in their research! Click here to take the survey.
“Current research evidence highlights that influencing the endocannabinoid system is a promising way to treat glaucoma. Studies show that we can use this system to not only reduce eye pressure but also provide neuroprotection.
This latter finding is especially significant because some people with glaucoma continue to experience vision loss even after their eye pressure is reduced. As such, there’s a need for glaucoma medicines that address both eye pressure and neuronal damage.“
Materials from the Webinar
“Cytokines are signaling proteins that ultimately recruit inflammation to happen. Cytokines will trigger specific immune cells to release inflammation or actually even reduce inflammation, given the right circumstances. […] CBD actually modulates the cytokine production.”
Dr. Sanjay Gupta‘s enterprise reporting on medical marijuana has led to five documentary films, “Weed,” which were awarded the Alfred I. duPont-Columbia University Award.
Cannachats Recommended Reading
Glaucoma & Medical Marijuana
Cannabis Pharmacy: The practical guide to medical marijuana. Pgs 185-187. Backes, M. W. (2017).
Basics of Medical Marijuana in Florida
Medical Marijuana Patient Information Brochure
Medical Marijuana Awareness Webinars, in partnership with MMTCFL
Florida Medical Marijuana Patient Application
Click to Download from the Office of Medical Marijuana Use
The Cannabis Health Index, pgs. 259-264. Uwe Blesching, P. (2015).
Common Eye Disorders. Centers for Disease Control and Prevention, C. (2015). Retrieved from Vision Health Initiative.
Delta9-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity. American Journal of Pathology, 1997-2008.
What Is Linalool & What Are the Effects of This Cannabis Terpene? Kaplan, J. (2018, April 23). Retrieved from Leafly
Evidence for the involvement of Ionotropic Glutamatergic Receptors on the Antinociceptive Effect of (-)-Linalool in Mice. P.A. Batista, M.F. Werner, E.C. Oliveira, L. Burgos, P. Pereira, L.F. Brum, & A.R Santos. (2008). Neuroscience Letters, 299-303.
Effect of Sublingual Application of Cannabinoids on Intraocular Pressure: A Pilot Study. Tomida, Ileana & Azuara-Blanco, Augusto & House, Heather & Flint, Maggie & Pertwee, Roger & Robson, Philip. (2006). Journal of glaucoma, 349-53.
5 Best Cannabis Strains for Glaucoma. Marijuana Break, S. (2020, March 4). Retrieved from Marijuana Break
Neuroprotection by (endo)Cannabinoids in Glaucoma and Retinal Neurodegenerative Diseases. Rapino, C., Tortolani, D., Scipioni, L., & Maccarrone, M. (2018). Current neuropharmacology, 959-970.